What is your profession?
MDNP DOOncology Nurse PhDNurse PA/PA-COther (please specify)

What Board Certifications do you have?
Med OncOncology Surgeon HematologistInternal Medicine Hem/OncFamily Practice Surgical OncOther (please specify) Radiation Onc

What is your primary specialty?
General OncologyHead, Neck, or Lung Cancers Gastrointestinal CancersGynecologic Cancer Genitourinary CancersHematological Malignancies Breast CancerOther

May we e-mail you for further clarification of your comments?
Yes No

How would you describe this course to your colleagues?

What in the program description did you find most compelling? Did your experience match your expectations?

Have you attended a prior Dana-Farber Master Class for Oncologists?
Yes No

If yes, how does this year’s program compare?

How does Dana-Farber Master Class compare to other CME programs you’ve attended?

Of the sessions currently in the course, which did you find MOST engaging? Please explain.

Which sessions did you find LEAST valuable? Please explain.

What activity or topic would you like to see in future Master Class courses? Please explain.

Please identify and provide feedback (knowledge, quality of presentation style, level of content) for each track you attended.

Please identify you how you will use information from each track in your clinical practice.

Select the tracks you attended


	Success You have claimed credit successfully. Print your certificate

April 26 - 27 San Francisco, CA Register >

The Fairmont Hotel
950 Mason Street

Tuition fee is $150 – December 4 – March 29

Tuition fee is $250 – March 30 – April 17

Registration closes – April 17

Agenda

Accreditation

Accommodations

Agenda

Friday

06:30 AM - 07:15 AM	Registration and Breakfast
07:15 AM - 07:30 AM	Opening Remarks

Breast Cancer Track

07:30 AM - 08:20 AM	High Risk Breast Cancer: Diagnosis and Management of Patients with Hereditary Cancers Judy E. Garber
08:20 AM - 09:10 AM	Treating Breast Cancer Subtypes: Current and Emerging Evidence in HER2+, Triple Negative, and Other Subtypes Eric P. Winer, MD
09:10 AM - 09:50 AM	Hormone Receptor Positive Breast Cancer: Initial Treatment and Long Term Management Choices Harold J. Burstein, MD, PhD; Track Director

09:50 AM - 10:05 AM	Break

Breast Cancer Track

10:05 AM - 10:40 AM	Breast Cancer Survivorship: Strategies That Promote Health and Quality of Life in Breast Cancer Patients After Treatment is Finished Ann H. Partridge, MD, MPH
10:40 AM - 11:10 AM	Panel Discussion

Supportive Care Track

11:10 AM - 11:50 AM	Palliative and Supportive Care: A Comprehensive Guide to Caring for Your Patients Janet L. Abrahm, MD, FACP, FAAHPM

11:50 AM - 01:00 PM	Lunch
11:55 AM - 01:00 PM	Optional Performance Improvement (MOC Part IV) Initiative Overview: Gastrointestinal and Breast F. Steven Hodi, Jr., MD, Paul G. Richardson, MD

Sarcomas Track

01:00 PM - 01:30 PM	Sarcomas and GIST: Current Management and a Look Towards the Future George D. Demetri, MD

Gastrointestinal Cancer Track

01:30 PM - 02:20 PM	Esophageal, Gastric and Pancreatic Cancers: How to Improve Survival for These Deadly Cancers Peter C. Enzinger, MD
02:20 PM - 03:05 PM	Familial Gastrointestinal Cancers: Personalized Strategies for Diagnosis and Management Sapna Syngal, MD, MPH

03:05 PM - 03:20 PM	Break

Gastrointestinal Cancer Track

03:20 PM - 04:10 PM	Preventing the Development and the Recurrence of Gastrointestinal Cancers through Lifestyle Practices: Recent and Emerging Clinical Data Charles S. Fuchs, MD, MPH
04:10 PM - 05:00 PM	Adjuvant and Metastatic Colon Cancer: Evidence-Based Therapeutic Choices Robert J. Mayer, MD; Course Chair/Track Director
05:00 PM - 05:30 PM	Panel Discussion

05:30 PM - 05:35 PM	Course Adjournment
06:00 PM - 08:30 PM	Optional Maintenance of Certification (MOC Part II ) Session Updates in Oncology Harold J. Burstein, MD, PhD, Daniel J. DeAngelo, MD PhD, Robert J. Mayer, MD

Saturday

06:30 AM - 07:15 AM	Registration and Continental Breakfast
07:15 AM - 07:30 AM	Welcome and Opening Remarks

Genitourinary Cancers Track

07:30 AM - 08:20 AM	Advanced and Metastatic Prostate Cancer: Emerging Therapeutic Approaches Philip W. Kantoff, MD
08:20 AM - 08:55 AM	Bladder and Renal Cancer: Integrating New Therapies into Current Best Practices Robert Dreicer, MD

Head, Neck, and Lung Cancers Track

08:55 AM - 09:40 AM	Head and Neck Cancer: Changing Epidemiology and Evolving Interdisciplinary Management Robert I. Haddad, MD

09:40 AM - 09:55 AM	Break

Head, Neck, and Lung Cancers Track

09:55 AM - 10:30 AM	Non-Small Cell Lung Cancer: Current and Emerging First Line Approaches Pasi A. Jänne, MD, PhD
10:30 AM - 11:05 AM	Selected Topics in Lung Cancer: Previously Treated Non-Small Cell Lung Cancer and Advances in Small Cell Lung Cancer and Mesothelioma Bruce E. Johnson, MD; Track Director
11:05 AM - 11:30 AM	Panel Discussion

Melanomas Cancer Track

11:30 AM - 12:00 PM	Melanoma: Recent Advances and Emerging Clinical Data F. Steven Hodi, Jr., MD

12:00 PM - 01:00 PM	Lunch
12:05 PM - 01:00 PM	Optional Performance Improvement (MOC Part IV) Initiative Overview: Hematologic Malignancies and Head & Neck Daniel J. DeAngelo, MD PhD, Robert I. Haddad, MD

Hematologic Malignancies Track

01:00 PM - 01:55 PM	Lymphomas: Current and Emerging Therapies for Non-Hodgkins and Hodgkins Lymphomas Arnold S. Freedman, MD; Track Director
01:55 PM - 02:50 PM	Myeloid Malignancies: Evidence-Based Best Practices for Molecular Testing, Risk Assessment, and Therapeutic Management Daniel J. DeAngelo, MD PhD
02:50 PM - 03:30 PM	Myeloproliferative Disorders: Diagnosis, Risk Assessment, and Evolving Management Strategies Ayalew Tefferi, MD

03:30 PM - 03:45 PM	Break

Hematologic Malignancies Track

03:45 PM - 04:20 PM	Multiple Myeloma: Novel Treatment Strategies in Multiple Myeloma Kenneth C. Anderson, MD
04:20 PM - 04:55 PM	Chronic Lymphocytic Leukemia: Best Practices for Assessing Risk and Integrating Current and Emerging Therapeutic Approaches John C. Byrd, MD
04:55 PM - 05:25 PM	Panel Discussion

05:25 PM - 05:30 PM	Program Adjournment

© Copyright Dana-Farber Cancer Institute. All rights reserved.
This course is jointly sponsored by Dana-Farber Cancer Institute, Knowledge to Practice and Annenberg Center for Health Sciences.

For questions or more information on our live courses or online activities, please contact:
Laurie Bertoncini, Program Manager
Phone: 610-361-9720 | Email: LBertoncini@KnowledgeToPractice.org